Kedaara Capital has completed a US$240 million transaction involving Axtria, a data analytics and cloud software firm focused on the global life sciences sector.

The deal, which combines a secondary investment and company-sponsored buyback, provides liquidity to Axtria’s current and former employees as well as early investors.

The companies said this is one of the largest employee-focused liquidity events in the industry.

Founded in 2010, Axtria offers AI-powered solutions and software to clients in the pharmaceutical and life sciences sectors, supporting over 100 firms in more than 75 countries.

🔗 Source: Kedaara